Apoptosis regulators and their role in tumorigenesis

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Programmed cell death (PCD) is a critical biological process that eliminates unwanted or damaged cells.
• Dysregulation of PCD is increasingly recognized as a significant factor in the development and progression of cancer.
• Many cancer-promoting mutations target and disrupt the molecular pathways governing PCD.

Purpose of the Study:

• To review the genes and molecular mechanisms underlying programmed cell death (PCD).
• To summarize the evidence linking impaired PCD to tumorigenesis.
• To explore the therapeutic potential of restoring defective PCD pathways in cancer treatment.

Main Methods:

• Literature review of genes and mechanisms involved in PCD.
• Analysis of evidence supporting the role of impaired PCD in cancer.
• Discussion of therapeutic strategies targeting PCD.

Main Results:

• Programmed cell death (PCD) is a fundamental process that, when inhibited, contributes significantly to cancer.
• Numerous genetic mutations found in tumors directly interfere with PCD pathways.
• Evidence strongly suggests that defective PCD is a necessary step for cancer to arise.

Conclusions:

• Inhibition of programmed cell death (PCD) is a key hallmark of cancer.
• Understanding the molecular basis of PCD is essential for cancer research.
• Targeting and restoring 'death programs' represents a novel and promising strategy for cancer therapy.